Word

SEVALENT

Status

Pending

Status Code

654

Status Date

Thursday, January 11, 2024

Serial Number

97583886

Mark Type

4000

Filing Date

Thursday, September 8, 2022

Trademark Owner History

Bexson Biomedical, Inc.

Classifications

5 Pharmaceutical preparations for reducing, managing and relieving pain, treating addiction disorders and treating mental health illnesses; pharmaceutical preparations consisting of ketamine, flumazenil and psychedelics for the treatment of pain, addiction disorders and mental health illnesses; pharmaceutical preparations, namely, medicinal psychoactive psychedelic therapies for the treatment of pain, addiction disorders and mental health illnesses; drug delivery agents in the form of small molecules for the controlled release of therapeutic agents; wearable drug delivery devices, namely, subcutaneous pumps, sold filled with pharmaceutical preparations, for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses

35 providing business information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

45 providing regulatory compliance information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

44 providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

10 Wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for pain management, reduction and relief, addiction disorders, and mental health illnesses

42 Medical and scientific research in the fields of addiction disorders, mental health illnesses, pain management, reduction and relief; developing modular subcutaneous delivery platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor

Trademark Events

Jan 11, 2024

Report Completed Suspension Check Case Still Suspended

Jul 12, 2023

Notification Of Letter Of Suspension E-Mailed

Jul 12, 2023

Letter Of Suspension E-Mailed

Jul 12, 2023

Suspension Letter Written

Jul 11, 2023

Teas/Email Correspondence Entered

Jul 10, 2023

Correspondence Received In Law Office

Jul 10, 2023

Teas Response To Office Action Received

Jun 22, 2023

Notification Of Non-Final Action E-Mailed

Jun 22, 2023

Non-Final Action E-Mailed

Jun 22, 2023

Non-Final Action Written

Jun 22, 2023

Assigned To Examiner

Sep 26, 2022

New Application Office Supplied Data Entered

Sep 12, 2022

New Application Entered